Cita APA

Alcon, C., Martín, F., Prada, E., Català-Mora, J., Soriano, A., Guillén, G., . . . Montero, J. (2022). MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.

Citación estilo Chicago

Alcon, Clara, et al. MEK and MCL-1 Sequential Inhibition Synergize to Enhance Rhabdomyosarcoma Treatment. 2022.

Cita MLA

Alcon, Clara, et al. MEK and MCL-1 Sequential Inhibition Synergize to Enhance Rhabdomyosarcoma Treatment. 2022.